Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 111,065 | 203,566 | 312,420 | 561,572 | 616,214 |
| Marketable Securities | 350,797 | 270,125 | 204,502 | N/A | N/A |
| Receivables | 22,359 | 23,126 | 27,170 | 22,443 | 23,942 |
| TOTAL | $506,082 | $523,025 | $564,534 | $602,744 | $662,480 |
| Non-Current Assets | |||||
| PPE Net | 176,579 | 186,354 | 197,828 | 203,720 | 211,035 |
| Investments And Advances | 30,175 | 32,662 | 32,173 | 48,704 | 62,103 |
| Intangibles | 61,522 | 66,152 | 68,756 | 72,510 | 79,566 |
| Other Non-Current Assets | 414,807 | 422,816 | 430,172 | 449,771 | 465,699 |
| TOTAL | $683,083 | $707,984 | $728,929 | $774,705 | $818,403 |
| Total Assets | $1,189,165 | $1,231,009 | $1,293,463 | $1,377,449 | $1,480,883 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,704 | 11,202 | 11,267 | 14,169 | 15,700 |
| Accrued Expenses | 79,341 | 57,231 | 70,747 | 65,387 | 75,833 |
| TOTAL | $115,281 | $96,720 | $115,667 | $107,266 | $114,427 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 25,236 | 28,287 | 33,653 | 27,710 | 22,894 |
| Other Non-Current Liabilities | 440,029 | 446,771 | 449,991 | 455,342 | 463,266 |
| TOTAL | $514,101 | $521,337 | $530,369 | $554,125 | $568,513 |
| Total Liabilities | $629,382 | $618,057 | $646,036 | $661,391 | $682,940 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,590 | 59,200 | 58,532 | 58,034 | 57,479 |
| Common Shares | 6 | 6 | 5 | 5 | 5 |
| Retained earnings | -6,069,569 | -5,988,814 | -5,928,514 | -5,837,557 | -5,730,023 |
| Other shareholders' equity | 1,996 | 1,653 | -850 | -1,806 | 263 |
| TOTAL | $559,783 | $612,952 | $647,427 | $716,058 | $797,943 |
| Total Liabilities And Equity | $1,189,165 | $1,231,009 | $1,293,463 | $1,377,449 | $1,480,883 |